Social Functioning Deficits in Young People at Risk for Schizophrenia

Shim, Geumsook; Kang, Do‐Hyung; Chung, Yu Sun; Yoo, So Young; Shin, Na Young; Kwon, Jun Soo

doi:10.1080/00048670802203459

Cited by 49 publications

(44 citation statements)

References 48 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent studies using more specific measures confirm current impairments of social and/or role functioning (Addington et al, 2008; Ballon et al, 2007; Shim et al, 2008). …”

Section: Aps Syndrome Patients Are Currently Illmentioning

confidence: 89%

The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome

Woods

Walsh

Saksa

et al. 2010

Schizophrenia Research

106

View full text Add to dashboard Cite

The American Psychiatric Association Task Force on DSM-5 has recently proposed consideration of Attenuated Psychotic Symptoms Syndrome as a new diagnosis, based on nearly 15 years of prospective research in centers across the globe. The condition is also known as "psychosis risk syndrome," "at-risk mental state," "ultra-high risk," and "putative prodrome." We review evidence favoring its inclusion as a new diagnosis in DSM-5 and report new preliminary findings on DSM-IV diagnoses in current clinical use for these patients and on results of diagnostic interviews in unselected volunteers.The main evidence supporting inclusion is: (1) the patients are currently ill, (2) the patients are at high risk for getting worse, (3) no DSM-IV diagnosis accurately captures their current illness or future risk, (4) the diagnosis has been made with reliability and validity in the research setting, and (5) placement in DSM-5 would help promote the needed treatment and prevention research to enable articulation of a standard of care to benefit these patients and their families. Potential harms can be minimized by patient, family, and provider education. It will be important to demonstrate through well-designed field trials whether the diagnostic criteria can be used with reliability in everyday clinical practice.

show abstract

“…Recent studies using more specific measures confirm current impairments of social and/or role functioning (Addington et al, 2008; Ballon et al, 2007; Shim et al, 2008). …”

Section: Aps Syndrome Patients Are Currently Illmentioning

confidence: 89%

The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome

Woods

Walsh

Saksa

et al. 2010

Schizophrenia Research

106

View full text Add to dashboard Cite

show abstract

“…Four other studies with some resemblance to ours have used other instruments to assess social functioning and to compare groups with increasing illness severity Ballon et al, 2007;Pinkham et al, 2007;Shim et al, 2008). In all the papers the conclusion was that the at-risk population meeting criteria for prodromal state had impaired or significantly impaired social functioning compared to healthy control individuals.…”

Section: The Materialsmentioning

confidence: 90%

“…(3) studies of communication in families with occurrence of a schizophrenia spectrum disorder (McFarlane & Cook, 2007); (4) studies on social parameters predicting the risk for psychosis (Cannon et al, 2008;Häfner et al, 1995;Hans et al, 2000); and (5) studies comparing social functioning deficits during the course of psychosis Ballon et al, 2007;Pinkham et al, 2007;Shim et al, 2008).…”

Section: Introductionmentioning

confidence: 99%

Interpersonal problems in the prodromal state of schizophrenia: An exploratory study

Mondrup

Rosenbaum

2009

Psychosis

View full text Add to dashboard Cite

Decline in social function and withdrawal from interpersonal relations often precede psychotic symptoms in developing psychosis. It is therefore of interest to assess how persons presumed to be in the prodromal state of schizophrenia experience interpersonal difficulties. In this study a sample was defined by the Structured Interview for Prodromal Syndromes (SIPS) and interpersonal problems were assessed by the Inventory of Interpersonal Problems (IIP). Four groups were compared: a norm group (n=363), a group with sub-threshold symptoms (n=11), the group defined as prodromal (n=12) and a group meeting criteria for psychosis (n=12). The results showed an increase in interpersonal problems with increasing severity of near-psychotic and psychotic symptoms. Psychotherapeutic implications of focusing on interpersonal problems are discussed. Interpretation of the results must take into consideration that the sample was small. IntroductionDuring the past century, interpersonal and social difficulties experienced by people diagnosed with schizophrenia have been discussed from many clinical and research perspectives. These perspectives range from Bleuler's concept of autism to the recent phenomenological focus on intersubjectivity, and from studies of communication in families, to research in social cognition. Psychotic symptoms are often preceded by withdrawal from interpersonal relationships and decline in social function. Research into interpersonal problems in the prodromal state may therefore allow us to better understand the underlying mechanisms of the overt behaviour, and may, moreover, hold the key to more specific treatment interventions.The literature investigating social functioning and social deficits in the prodromal state has increased during the last few years and seems to fall within the following categories:

show abstract

“…However, this could be due to increased symptom severity prior to the assessment that warranted the use of medication. In contrast, a small, uncontrolled, open-label study found that ARMS patients' prescribed antipsychotic medication experienced significant, but modest improvement in functioning, though this remained markedly impaired compared to the general population (Shim et al, 2008b). An open-label study examining a needs-focused intervention delivered with or without amisulpride also reported significantly better global functioning after 12-weeks of treatment in those who received amisulpride (Ruhrmann et al, 2007).…”

Section: Antipsychotic Medicationmentioning

confidence: 93%